Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published February 16, 2018 | Submitted + Supplemental Material
Journal Article Open

Cell-Free and In Vivo Characterization of Lux, Las, and Rpa Quorum Activation Systems in E. coli

Abstract

Synthetic biologists have turned toward quorum systems as a path for building sophisticated microbial consortia that exhibit group decision making. Currently, however, even the most complex consortium circuits rely on only one or two quorum sensing systems, greatly restricting the available design space. High-throughput characterization of available quorum sensing systems is useful for finding compatible sets of systems that are suitable for a defined circuit architecture. Recently, cell-free systems have gained popularity as a test-bed for rapid prototyping of genetic circuitry. We take advantage of the transcription–translation cell-free system to characterize three commonly used Lux-type quorum activators, Lux, Las, and Rpa. We then compare the cell-free characterization to results obtained in vivo. We find significant genetic crosstalk in both the Las and Rpa systems and substantial signal crosstalk in Lux activation. We show that cell-free characterization predicts crosstalk observed in vivo.

Additional Information

© 2017 American Chemical Society. Received: October 16, 2017; Published: November 9, 2017. The authors would like to thank Sam Clamons, Andrey Shur and Vipul Singhal for fruitful discussions. We also thank John Marken for helpful comments on the manuscript. Plasmid vectors were provided by Douglas Densmore at the Cross-disciplinary Integration of Design Automation Research lab (Addgene Kit # 1000000059). The project depicted was sponsored by the Defense Advanced Research Projects Agency (Agreement HR0011-17-2-0008). The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The authors declare the following competing financial interest(s): RMM has ownership in a company that commercializes the cell-free system used in this manuscript.

Attached Files

Submitted - 159988.full.pdf

Supplemental Material - sb7b00376_si_001.pdf

Files

sb7b00376_si_001.pdf
Files (10.6 MB)
Name Size Download all
md5:a7a2b3a480db8a99c82124a0764d5862
2.8 MB Preview Download
md5:6310459186d9356b15e69ef14cc0c218
7.8 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023